Maeve O'Reilly

19PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PhysiotherapyHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 09, 2026
Methodological Challenges and Preferred Approaches for the Economic Evaluation of CAR T Therapies: Evidence Review and Expert Consensus from NICE Appraisals.

|Mar 08, 2026
Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival.

Maeve A O'Reilly, William Wilson, Bernard Maybury

|Dec 18, 2024
CD19-targeting chimeric antigen receptor T-cell therapy is safe and effective for intra-cardiac B cell non-Hodgkin lymphoma.

Daniel H Chen, Maeve O'Reilly, Kathleen P Cheok

|Oct 17, 2024
Single-centre experience of implementing physiotherapist-led prehabilitation for chimeric antigen receptor T cell therapy.

Orla McCourt, Paul Maciocia, Claire Roddie

|Jun 14, 2024
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis.

Maeve A O'Reilly, William Wilson, David Burns

|Apr 10, 2024
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK.

A Kuhnl, C Roddie, A A Kirkwood

Pageof 4

Frequent Collaborators

9 joint publications

Claire Roddie

5 joint publications

Andrea Kuhnl

3 joint publications

Robin Sanderson

3 joint publications

Angela Hwang